To evaluate the effectiveness of the SEE personalized glaucoma coaching program on medication adherence, glaucoma-related distress, and intraocular pressure in patients with glaucoma, focusing on specific outcome measures.
Key Findings:
The SEE program significantly improved medication adherence compared to the control group, with statistical significance noted.
Participants in the SEE group reported lower glaucoma-related distress, with specific metrics provided.
Intraocular pressure changes were also assessed but not highlighted as a primary finding, suggesting further exploration is needed.
Interpretation:
The SEE program effectively supports medication adherence and reduces distress in glaucoma patients, suggesting a viable model for chronic disease management.
Limitations:
The study was limited to English-speaking participants from specific health systems, which may affect generalizability.
Potential biases in self-reported adherence and the nonmasked design should be discussed in relation to the study's validity.
Conclusion:
The SEE personalized coaching program shows promise in enhancing medication adherence and reducing distress among glaucoma patients, warranting further research and broader implementation, particularly in diverse populations.
